VABK Q1 2026 Earnings Solid EPS Performance as Stock Edges Lower REX Q3 2001 Earnings EPS Beats Estimates by 23 on Strong Operating Performance ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64 SCWorx Corp WORX Q3 2025 Earnings Loss Per Share of 015 as Stock Surges SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds